ENTITY
CanariaBio

CanariaBio (016790 KS)

53
Analysis
Consumer Staples • South Korea
CANARIABIO Inc. operates as a new anticancer drugs development biotechnology company. The Company develops ovarian cancer, pancreatic cancer, gynecological cancer, and metastatic breast cancer immunotherapy drugs. CANARIABIO also produces sheep, pig, hog, poultry, and sweetened feed products.
more
bearish•CJ CGV Co Ltd
•31 Jul 2023 13:46

End of Mandatory Lock-Up Periods for 40 Companies in Korea in August 2023

We discuss the end of the mandatory lock-up periods for 40 stocks in Korea in August 2023, among which 2 are in KOSPI and 38 are in KOSDAQ.

Logo
477 Views
Share
bearish•Devsisters
•17 Nov 2022 04:55

KOSDAQ150 Index Rebalance: 11 Changes with a Couple of Surprises

There are 11 changes at the Dec rebal: mostly in line with forecasts. SillaJen is a surprise add; Devsisters is a surprise delete. Short interest...

Logo
696 Views
Share
•16 Nov 2022 20:52

KOSPI 200 & KOSDAQ 150 Rebalance Changes + KOSPI 200 & KOSDAQ 150 Exclusion Candidates in 2023

Korea Exchange announced the KOSPI 200, KOSDAQ 150, and KRX 300 rebalance changes today. Lotte Confectionery will be added and Samyang Holdings...

Logo
1k Views
Share
bearish•HPSP
•08 Nov 2022 01:56

Shorting Setup on Additions to KS200/KQ150 with KODEX Battery ETF Flow

This post examines the shorting situation of the KS200/KQ150 additions in the upcoming rebalancing with the potentially mitigating flow from the...

Logo
361 Views
Share
bullish•HPSP
•01 Nov 2022 04:40

KOSDAQ150 Index Rebalance Preview: Big Churn in IT, Healthcare Stocks

There could be 11 changes at the Dec rebalance. Most changes are high probability and will result in a big churn in the IT & Healthcare sectors....

Logo
556 Views
Share
x